Harout Semerjian was appointed as President and Chief Executive Officer at CRESCENT BIOPHARMA, INC..
“On August 2, 2021, the Board appointed Harout Semerjian as the Company’s President and Chief Executive Officer, effective as of August 6, 2021.”
CRESCENT BIOPHARMA, INC. — fact timeline
Source-grounded facts extracted from CRESCENT BIOPHARMA, INC.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Rachel K. King retired as President and Chief Executive Officer at CRESCENT BIOPHARMA, INC..
“On July 30, 2021, Rachel K. King, President and Chief Executive Officer of the Company, notified the Board of Directors of the Company (the “ Board ”) of her decision to retire from those positions, effective as of August 6, 2021.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.